ProShares Ultra NASDAQ Biotechnology (BIB)
NASDAQ
Fin d'année 31 Mai 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.401 | -0.404 | -21.581 | 43.326 | 15.553 | -34.705 | 5.342 | 5.731 |
Return on Equity (%) | -0.469 | -0.444 | -23.268 | 47.082 | 16.103 | -41.035 | 6.985 | 5.916 |
Return on Invested Capital (%) | 7 | 7.125 | -20.106 | -0.947 | -2.774 | -4.999 | 1.158 | 1.594 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 45.605 | 55.885 | 43.675 | 70.762 | 84.526 | 48.044 | 52.212 | 56.043 |
Earnings Per Share | -0.258 | -0.241 | -13.978 | 35.441 | 11.162 | -40.095 | 3.592 | 3.472 |
Cash Per Share | 0.494 | 0.032 | N/A | 6.37 | 2.887 | 29.11 | 0.235 | N/A |
Working Capital Per Share | -6.239 | 0.431 | 0.926 | 22.927 | 3.652 | 5.471 | 13.836 | 17.046 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | -0.258 | -0.241 | -13.978 | 35.441 | 11.162 | -40.095 | 3.612 | 3.557 |
Fin d'année 31 Mai 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 7,5M | 6,5M | 4,75M | 2,6M | 3,4M | 1,95M | 1,85M | 1,58M |
Fin d'année 31 Mai 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 79,54M |
Ratio cours/bénéfice | 14,83 |
Ratio prix/ventes | 64,47 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0,92 |
Rendement de dividende | 15,56% |
Actions en circulation | 1,58M |
Volume moyen (1 semaine) | 12,51k |
Volume moyen (1 mois) | 9,66k |
Variation sur 52 semaines | -3,49% |
Plus haut sur 52 semaines | 69,56 |
Plus bas sur 52 semaines | 47,195 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales